Related Experiment Video
Updated: Feb 10, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.3K
Metastatic osteosarcoma: a challenging multidisciplinary treatment
Cristina Meazza1, Paolo Scanagatta2
1a Pediatric Oncology Unit , Fondazione IRCCS Istituto Nazionale dei Tumori , Milano , Italy.
Expert Review of Anticancer Therapy
|March 22, 2016
Summary
Osteosarcoma, a common bone cancer, has poor survival rates for patients with lung metastases. Complete surgical removal is crucial, but innovative treatments are needed for those with widespread disease.
Area of Science:
- Oncology
- Orthopedic Surgery
- Medical Oncology
Background:
- Osteosarcoma is the most frequent primary malignant bone tumor.
- Current treatment involves chemotherapy and surgical tumor removal.
- Metastatic disease, primarily to the lungs, presents a significant challenge.
Purpose of the Study:
- To review the current management of osteosarcoma, particularly focusing on metastatic disease.
- To highlight the prognostic differences based on metastatic patterns.
- To emphasize the need for standardized treatment protocols for complex cases.
Main Methods:
- Review of existing literature on osteosarcoma treatment and outcomes.
- Analysis of prognostic factors in localized versus metastatic osteosarcoma.
- Discussion of surgical resection and chemotherapy's role.
Main Results:
- Approximately 15-20% of osteosarcoma patients have metastases at diagnosis.
- Long-term survival is significantly lower in metastatic cases (20-30%) compared to localized disease (65-70%).
- Complete surgical resection of all disease sites is a key predictor of survival.
Conclusions:
- Optimal management for metastatic osteosarcoma is not yet standardized.
- Complete surgical removal is essential for improving survival.
- Patients with multiple unresectable metastatic sites require consideration for novel therapeutic strategies due to their poor prognosis.
Keywords:
Chemotherapydifferent patterns of diseasegenomic complexitymultidisciplinarysurgerysurvivaltailored therapytargeted drugsMore Related Videos
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
11.5K
07:44Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
10.7K
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:24Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
01:22Alzheimer's Disease: Treatment
968
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968
01:26Anticholinesterase Agents: Poisoning and Treatment
1.7K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K
01:28Angle Closure Glaucoma: Treatment
1.3K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.3K